Investigator is the go-to exceptions management solution for the FDA’s Enhanced Supply Chain Security requirement, a 2023 mandate under the Drug Supply Chain Security Act (DSCSA). It manages the errors and failures that arise from new DSCSA transactions including EPCIS and VRS.
Thanks. You will be redirected in a second...
Oops! Something went wrong while submitting the form.
“LSPedia's OneScan allows us to work smarter, manage technical issues and negative verifications better, and not find it necessary to hire FTEs and throw other resources at the problem. OneScan is the only solution that solves the management of anticipated volumes of negative verifications. In addition, it gives us the ability to manage suspect/illegitimate products and file FDA 3911 notifications in one place and do trading partner notifications when required.”
“We feel the pain when EPCIS files are late or error out. Shipments get set aside and pile up at receiving. With our volume, it’s impossible for us to check and catch errors manually. This needs to be addressed with automation and, OneScan is, in my mind, the best product out there to help with exceptions management.”
"LSPedia OneScan has been instrumental in managing partners and getting the EPCIS data. My CEO and I placed our trust into LSPedia. I am just happy that LSPedia is in our corner because I don’t have time to check EPCIS for errors. We are a small company. I wear a lot of hats. OneScan took a lot of burden away from us which gives me more time to generate revenue.”
"My experience with LSPedia has been exceptional, and the customer service has been fantastic. I am confident that LSPedia will continue to provide us with compliance to the regulations set forth by DSCSA.”
"LSPedia's cost was in-line, it's user-friendly, but most of all it was the support and trust we have in LSPedia beyond almost anything. We have just had a really positive relationship for approximately seven years."